Bloomberg -- Fujifilm Holdings Corp. will buy two units of Merck & Co. that make biopharmaceuticals as it targets growth in the health-care industry to make up for declining sales in cameras and film. The Tokyo-based maker of imaging equipment and digital cameras will acquire laboratories in the U.S. and U.K. for 40 billion yen ($490 million), Nikkei English News reported today without saying where it got the pricing information. Toshihiro Matsumoto, a Fujifilm spokesman, confirmed the purchase by phone today, without giving a price.
